The effect of LDLR-negative genotype on CT coronary atherosclerosis in asymptomatic statin treated patients with heterozygous familial hypercholesterolemia

Atherosclerosis

Volumn 227, Issue 2, 2013, Pages 334-341

  ten Kate, Gert Jan R ^a,b   Neefjes, Lisan A ^a,b   Dedic, Admir ^a   Nieman, Koen ^a   Langendonk, Janneke G ^a   Galema Boers, Annette J ^a   Roeters van Lennep, Jeanine ^a   Moelker, Adriaan ^a   Krestin, Gabriel P ^a   Sijbrands, Eric J ^a   de Feyter, Pim J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Asymptomatic; Atherosclerosis; Coronary calcium score; Coronary CT angiography; Diseased segments score; Familial hypercholesterolemia; Low density lipoprotein receptor

Indexed keywords

APOLIPOPROTEIN B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; SECONDARY ANALYSIS;

ADULT; APOLIPOPROTEINS B; CORONARY ARTERY DISEASE; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENOTYPE; HETEROZYGOTE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; RECEPTORS, LDL;

EID: 84875055351     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.12.016     Document Type: Article

References (30)

1. Guardamagna O., Restagno G., Rolfo E., et al. The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia. J Pediatr 2009, 155:199 e2-204 e2.
2. Neefjes L.A., Ten Kate G.J., Alexia R., et al. Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia. Atherosclerosis 2011, 219:721-727.
3. Neefjes L.A., Ten Kate G.J., Rossi A., et al. CT coronary plaque burden in asymptomatic patients with familial hypercholesterolaemia. Heart 2011, 97:1151-1157.
4. Gudnason V., Day I.N., Humphries S.E. Effect on plasma lipid levels of different classes of mutations in the low-density lipoprotein receptor gene in patients with familial hypercholesterolemia. Arterioscler Thromb 1994, 14:1717-1722.
5. Gaudet D., Vohl M.C., Couture P., et al. Contribution of receptor negative versus receptor defective mutations in the LDL-receptor gene to angiographically assessed coronary artery disease among young (25-49 years) versus middle-aged (50-64 years) men. Atherosclerosis 1999, 143:153-161.
6. Sijbrands E.J., Westendorp R.G., Paola Lombardi M., et al. Additional risk factors influence excess mortality in heterozygous familial hypercholesterolaemia. Atherosclerosis 2000, 149:421-425.
7. Civeira F. International Panel on Management of Familial H. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis 2004, 173:55-68.
8. Marks D., Thorogood M., Neil H.A., Humphries S.E. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis 2003, 168:1-14.
9. Brown M.S., Goldstein J.L. Receptor-mediated control of cholesterol metabolism. Science 1976, 191:150-154.
10. Fouchier S.W., Kastelein J.J., Defesche J.C. Update of the molecular basis of familial hypercholesterolemia in the Netherlands. Hum Mutat 2005, 26:550-556.
11. de Sauvage Nolting P.R., Defesche J.C., Buirma R.J., Hutten B.A., Lansberg P.J., Kastelein J.J. Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia. J Intern Med 2003, 253:161-168.
12. Hobbs H.H., Russell D.W., Brown M.S., Goldstein J.L. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet 1990, 24:133-170.
13. Jansen A.C., van Wissen S., Defesche J.C., Kastelein J.J. Phenotypic variability in familial hypercholesterolaemia: an update. Curr Opin Lipidol 2002, 13:165-171.
14. Austin M.A., Hutter C.M., Zimmern R.L., Humphries S.E. Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol 2004, 160:421-429.
15. Bertolini S., Cantafora A., Averna M., et al. Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol 2000, 20:E41-E52.
16. Vohl M.C., Tchernof A., Dionne F.T., et al. The apoB-100 gene EcoRI polymorphism influences the relationship between features of the insulin resistance syndrome and the hyper-apoB and dense LDL phenotype in men. Diabetes 1996, 45:1405-1411.
17. Vohl M.C., Gaudet D., Moorjani S., et al. Comparison of the effect of two low-density lipoprotein receptor class mutations on coronary heart disease among French-Canadian patients heterozygous for familial hypercholesterolaemia. Eur J Clin Invest 1997, 27:366-373.
18. Sijbrands E.J., Westendorp R.G., Defesche J.C., de Meier P.H., Smelt A.H., Kastelein J.J. Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ 2001, 322:1019-1023.
19. Meijboom W.B., Meijs M.F., Schuijf J.D., et al. Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study. J Am Coll Cardiol 2008, 52:2135-2144.
20. Weustink A.C., Mollet N.R., Neefjes L.A., et al. Diagnostic accuracy and clinical utility of noninvasive testing for coronary artery disease. Ann Intern Med 2010, 152:630-639.
21. van Aalst-Cohen E.S., Jansen A.C., Tanck M.W., et al. Diagnosing familial hypercholesterolaemia: the relevance of genetic testing. Eur Heart J 2006, 27:2240-2246.
22. Umans-Eckenhausen M.A., Defesche J.C., Sijbrands E.J., Scheerder R.L., Kastelein J.J. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet 2001, 357:165-168.
23. Weustink A.C., Mollet N.R., Pugliese F., et al. Optimal electrocardiographic pulsing windows and heart rate: effect on image quality and radiation exposure at dual-source coronary CT angiography. Radiology 2008, 248:792-798.
24. Shrimpton P.C., Wall B.F., Yoshizumi T.T., Hurwitz L.M., Goodman P.C. Effective dose and dose-length product in CT. Radiology 2009, 250:604-605.
25. Austen W.G., Edwards J.E., Frye R.L., et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for grading of coronary artery disease, council on cardiovascular surgery, American Heart Association. Circulation 1975, 51:5-40.
26. Min J.K., Shaw L.J., Devereux R.B., et al. Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol 2007, 50:1161-1170.
27. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
28. Fouchier S.W., Defesche J.C., Umans-Eckenhausen M.W., Kastelein J.P. The molecular basis of familial hypercholesterolemia in the Netherlands. Hum Genet 2001, 109:602-615.
29. Heath K.E., Gudnason V., Humphries S.E., Seed M. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia. Atherosclerosis 1999, 143:41-54.
30. Van Gaal L.F., Peeters A.V., De Block C.E., de Leeuw I.H., Thiart R., Kotze M.J. Low-density lipoprotein receptor gene mutation analysis and clinical correlation in Belgian hypercholesterolaemics. Mol Cell Probes 2001, 15:329-336.